Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer. [electronic resource]
Producer: 20191119Description: 6509-6522 p. digitalISSN:- 1557-3265
- Androgen Receptor Antagonists -- chemistry
- Animals
- Antineoplastic Agents, Hormonal -- chemistry
- Cell Line, Tumor
- Disease Models, Animal
- Drug Discovery -- methods
- Drug Screening Assays, Antitumor
- Gene Expression Profiling
- High-Throughput Screening Assays
- Humans
- Male
- Mice
- Promoter Regions, Genetic
- Prostatic Neoplasms -- drug therapy
- Protein Binding
- Receptors, Androgen -- metabolism
- Structure-Activity Relationship
- Xenograft Model Antitumor Assays
- ets-Domain Protein Elk-1 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.